Lynwood Capital Management Inc. Kiromic Biopharma, Inc. Transaction History

Lynwood Capital Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$0.26 - $0.87 $78,000 - $261,000	-300,000 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$0.6 - $1.82 $43,500 - $131,950	-72,500 Reduced 19.46%	300,000 $256,000
Q4 2021 Feb 11, 2022	BUY	$1.53 - $3.12 $569,925 - $1.16 Million	372,500 New	372,500 $570,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $14.4M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Lynwood Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Lynwood Capital Management Inc. with notifications on news.